Next-gen cancer therapy without the next-gen price tag

Everything went according to plan in January when experts at Christiana Care's Helen F. Graham Cancer Center & Research Institute treated their first cervical cancer patient with integrated magnetic resonance imaging (MRI)-based planning for high-dose-rate (HDR) brachytherapy. The event marked a significant technological step forward in cancer treatment for patients in Delaware, and it also exemplified Christiana Care's focus on using resources wisely and effectively. Read more